ABCD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.917600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.225200E-01
Normal-vs-Stage2
7.278400E-01
Normal-vs-Stage3
3.194400E-01
Normal-vs-Stage4
2.561400E-01
Stage1-vs-Stage2
3.499600E-01
Stage1-vs-Stage3
1.248590E-01
Stage1-vs-Stage4
8.514400E-01
Stage2-vs-Stage3
1.748780E-01
Stage2-vs-Stage4
2.141200E-01
Stage3-vs-Stage4
3.229800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.222600E-01
Normal-vs-AfricanAmerican
3.025600E-01
Normal-vs-Asian
7.449800E-01
Caucasian-vs-AfricanAmerican
8.867600E-02
Caucasian-vs-Asian
8.594800E-01
AfricanAmerican-vs-Asian
1.285240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.236600E-01
Normal-vs-Female
6.628400E-01
Male-vs-Female
5.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.613200E-01
Normal-vs-Age(41-60Yrs)
4.885000E-01
Normal-vs-Age(61-80Yrs)
8.205200E-01
Normal-vs-Age(81-100Yrs)
9.172800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.540800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.354400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.923600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.389700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.373400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.703800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.053800E-01
Normal-vs-Daily Drinker
9.459200E-01
Normal-vs-Weekly Drinker
6.089200E-01
Normal-vs-Occasional Drinker
3.011400E-01
Normal-vs-Social Drinker
6.659800E-01
Non Drinker-vs-Daily Drinker
9.344000E-01
Non Drinker-vs-Weekly Drinker
2.509600E-01
Non Drinker-vs-Occasional Drinker
2.717500E-02
Non Drinker-vs-Social Drinker
5.116000E-01
Daily Drinker-vs-Weekly Drinker
3.504000E-01
Daily Drinker-vs-Occasional Drinker
4.681700E-02
Daily Drinker-vs-Social Drinker
5.231000E-01
Weekly Drinker-vs-Occasional Drinker
8.602400E-03
Weekly Drinker-vs-Social Drinker
1.155790E-01
Occasional Drinker-vs-Social Drinker
1.898370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.773360E-01
Normal-vs-Grade 2
1.128170E-01
Normal-vs-Grade 3
7.061600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.189800E-01
Grade 1-vs-Grade 3
5.184400E-01
Grade 1-vs-Grade 4
1.773360E-01
Grade 2-vs-Grade 3
8.806800E-01
Grade 2-vs-Grade 4
1.128170E-01
Grade 3-vs-Grade 4
7.061600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.658400E-01
Normal-vs-NonDiabetic
7.376400E-01
Diabetic-vs-NonDiabetic
3.837200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.447200E-01
Normal-vs-NoPancreatitis
8.007600E-01
Pancreatitis-vs-NoPancreatitis
7.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.689800E-01
Normal-vs-N1
7.171400E-01
N0-vs-N1
4.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.055200E-01
Normal-vs-TP53-NonMutant
4.220800E-01
TP53-Mutant-vs-TP53-NonMutant
3.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
